MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.29−0.06 (-0.70%)
Close on Nov 17, 2026Market cap $47.38MP/E –Yield –
MiNK Therapeutics total assets
Total assets on the balance sheet at the end of each period.
MiNK Therapeutics's total assets was $9.62M at Jun 30, 2026. For fiscal 2025 it was $14.24M, up 148.9% from the year before. The highest annual figure on record is $40.24M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.24M | +148.9% |
| FY2024 | Dec 31, 2024 | $5.72M | +25.7% |
| FY2023 | Dec 31, 2023 | $4.55M | -78.8% |
| FY2022 | Dec 31, 2022 | $21.47M | -46.6% |
| FY2021 | Dec 31, 2021 | $40.24M | +783.4% |
| FY2020 | Dec 31, 2020 | $4.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.62M | +287.0% |
| Q1 FY2026 | Mar 31, 2026 | $10.38M | +143.2% |
| Q4 FY2025 | Dec 31, 2025 | $14.24M | +148.9% |
| Q3 FY2025 | Sep 30, 2025 | $14.96M | +102.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.48M | -75.9% |
| Q1 FY2025 | Mar 31, 2025 | $4.27M | -38.1% |
| Q4 FY2024 | Dec 31, 2024 | $5.72M | +25.7% |
| Q3 FY2024 | Sep 30, 2024 | $7.37M | -1.2% |
| Q2 FY2024 | Jun 30, 2024 | $10.32M | -14.8% |
| Q1 FY2024 | Mar 31, 2024 | $6.89M | -58.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.55M | -78.8% |
| Q3 FY2023 | Sep 30, 2023 | $7.46M | -70.5% |
| Q2 FY2023 | Jun 30, 2023 | $12.11M | -61.1% |
| Q1 FY2023 | Mar 31, 2023 | $16.59M | -54.1% |
| Q4 FY2022 | Dec 31, 2022 | $21.47M | -46.6% |
| Q3 FY2022 | Sep 30, 2022 | $25.26M | +519.6% |
| Q2 FY2022 | Jun 30, 2022 | $31.12M | +583.1% |
| Q1 FY2022 | Mar 31, 2022 | $36.14M | – |
| Q4 FY2021 | Dec 31, 2021 | $40.24M | – |
| Q3 FY2021 | Sep 30, 2021 | $4.08M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.56M | – |
See a number that looks wrong?